Helene Lindfors, Ph.D. Student at the Endocrine Surgery research group, the Department of Molecular Medicine and Surgery, will defend her thesis "Tumor burden, thyroglobulin and Ki-67 as prognostic ...

A new research perspective was published in Volume 13 of Oncoscience on June 3, 2026, titled "The dual axis of tumorigenesis: ...

Papillary thyroid cancer is widely known as the "good cancer." This term has been around for years and is used ubiquitously. Some think it's "appropriate" because the cancer is highly treatable and ...

In a 10-center study, microwave ablation offered progression free survival rates and fewer complications than surgery in the treatment of a form of thyroid cancer known as papillary thyroid carcinoma ...

Efforts to curb overdiagnosis of thyroid cancer have made a difference in the United States and South Korea, but these countries still have high rates of excess treatment of indolent lesions, ...

Thyroid cancer is often a highly treatable disease. Most cases are detected in early stages and have excellent outcomes. There are several different types of thyroid cancer, and recent changes in ...

Global Burden of Thyroid Cancer in Adults Age 15-49 Years and Its Predictions: Findings From Global Burden of Disease Study 2021 We conducted whole-exome sequencing on 100 (N = 100) tumor-normal ...

Phase Ib Study of Navicixizumab Plus Paclitaxel in Patients With Platinum-Resistant Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Among 451 incident cases of papillary thyroid cancer and ...

Receiving a diagnosis of thyroid cancer can be upsetting and confusing, especially if a doctor suggests that a patient wait to see how the cancer progresses before pursuing any specific treatment.

A statistical modeling study estimated that 72% to 94% of papillary thyroid cancer diagnoses from 1991 to 2019 were overdiagnosed. Women had substantially higher rates of overdiagnosis. Reducing ...